FPR2 and arthritic joint disease: It has been shown that FPR2 ligation inhibits the expansion of effector pathogenic CD4+ T cells in two arthritis models, whereby FPR2 signaling enhances IL17 production in CD4+ T cells, while leaving IFNγ unchanged (33).